Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07225166 · ClinicalTrials.gov registry record
A Clinical Investigation Into the Association of an Impaired Skin Barrier and Infant and Toddler Sensitive Skin
A clinical trial, sponsored by Kenvue Brands.
- Completed
- Registry status
- 60
- Enrollment target
NCT07225166: Completed study, sponsored by Kenvue Brands.
NCT07225166 is a clinical trial that has completed, run by Kenvue Brands. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07225166 has completed, sponsored by Kenvue Brands.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
This is a Single center, evaluator-blinded clinical trial that intends to • Evaluate differences in TEWL measurements between parent-reported sensitive skin subjects and healthy subjects (subjects without sensitive skin) • Evaluate differences in skin capacitance between parent-reported sensitive skin subjects and healthy subjects (subjects without sensitive skin). A sufficient number of subjects pairs (comprised of a parent subject and a child subject) will be enrolled to complete the study with at least 60 subject pairs (30 subject pairs per group).
Primary Outcome
Higher values indicate greater hydration of the skin
Interventions
- OTHER Expert Clinical Grading
- OTHER Instrumental Measurements
- OTHER Parental Questionnaires
- OTHER Biomarker Measurements
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-10-01 |
| Est. Completion | 2025-11-05 |
What the finished NCT07225166 record still lists
NCT07225166 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which Expert Clinical Grading is the first listed.
NCT07225166 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07225166 about?
NCT07225166 is a clinical study titled "A Clinical Investigation Into the Association of an Impaired Skin Barrier and Infant and Toddler Sensitive Skin". This is a Single center, evaluator-blinded clinical trial that intends to • Evaluate differences in TEWL measurements between parent-reported sensitive skin subjects and healthy subjects (subjects without sensitive skin) • Evaluate differences in skin capacitance between parent-reported sensitive sk...
What is the current status of trial NCT07225166?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2025-10-01. Estimated completion is 2025-11-05.
What interventions are being tested in trial NCT07225166?
The interventions under investigation include: Expert Clinical Grading (OTHER), Instrumental Measurements (OTHER), Parental Questionnaires (OTHER), Biomarker Measurements (OTHER).
Who is sponsoring clinical trial NCT07225166?
This trial is sponsored by Kenvue Brands, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI